Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML

被引：46

作者：

Lokken, Alyson A. ^{[1
]}

Zeleznik-Le, Nancy J. ^{[1
,2
]}

机构：

[1] Loyola Univ Chicago, Inst Oncol, Maywood, IL 60153 USA

[2] Loyola Univ Chicago, Dept Med, Maywood, IL 60153 USA

来源：

CANCER CELL | 2012年 / 21卷 / 04期

关键词：

LSD1; COMPLEXES; PROTEINS;

D O I：

10.1016/j.ccr.2012.03.027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

KDM1A/LSD1, a histone H3K4/K9 demethylase and epigenetic regulator with roles in both gene activation and repression, has increased expression in multiple cancer types. Harris et al., in this issue of Cancer Cell, and Schenk et al. show that KDM1A may be a viable therapeutic target in treating AML.

引用

页码：451 / 453

页数：3

共 50 条

[21] KDM1A/ LSD1 inhibition enhances chemotherapy response in ovarian cancer
Johnson, Jessica D.
Chen, Yihong
Jayamohan, Sridharan
He, Yi
Jamwal, Diksha
Pandey, Neetesh
Kost, Edward
Vadlamudi, Ratna K.
Sareddy, Gangadhara R.
CANCER RESEARCH, 2024, 84 (06)
[22] KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer
Chen, Yihong
Johnson, Jessica D.
Jayamohan, Sridharan
He, Yi
Venkata, Prabhakar P.
Jamwal, Diksha
Alejo, Salvador
Zou, Yi
Lai, Zhao
Viswanadhapalli, Suryavathi
Vadlamudi, Ratna K.
Kost, Edward
Sareddy, Gangadhara R.
MOLECULAR CARCINOGENESIS, 2024, 63 (10) : 2026 - 2039
[23] Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features
Speranzini, Valentina
Rotili, Dante
Ciossani, Giuseppe
Pilotto, Simona
Marrocco, Biagina
Forgione, Mariantonietta
Lucidi, Alessia
Forneris, Federico
Mehdipour, Parinaz
Velankar, Sameer
Mai, Antonello
Mattevi, Andrea
SCIENCE ADVANCES, 2016, 2 (09):
[24] Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase
Laurent, B.
Shi, Y.
ENZYMES OF EPIGENETICS, PT A, 2016, 573 : 241 - 259
[25] Lysine-Specific Histone Demethylase, LSD1, (KDM1A) As a Novel Therapeutic Target in Myeloproliferative Neoplasms
Kleppe, Maria
Shank, Kaitlyn
Efthymia, Papalexi
Riehnhoff, Hugh
Levine, Ross L.
BLOOD, 2015, 126 (23)
[26] Synthesis of Carboxamide-Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia
Teresa Borrello, Maria
Benelkebir, Hanae
Lee, Adam
Hin Tam, Chak
Shafat, Manar
Rushworth, Stuart A.
Bowles, Kristian M.
Douglas, Leon
Duriez, Patrick J.
Bailey, Sarah
Crabb, Simon J.
Packham, Graham
Ganesan, A.
CHEMMEDCHEM, 2021, 16 (08) : 1316 - 1324
[27] Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)
Borrello, Maria Teresa
Schinor, Benjamin
Bartels, Katharina
Benelkebir, Hanae
Pereira, Sara
Al-Jamal, Wafa T.
Douglas, Leon
Duriez, Patrick J.
Packham, Graham
Haufe, Guenter
Ganesan, A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) : 2099 - 2101
[28] Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Song, Yihui
Zhang, Huiqing
Yang, Xiaoke
Shi, Yuting
Yu, Bin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 228
[29] Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib
Yi Zong
Zhigang Tao
Siyi Jiang
Minyuan Wang
Weihua Yu
Discover Oncology, 15
[30] Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules
Bibbo, Francesca
Asadzadeh, Fatemeh
Boccia, Angelo
Sorice, Carmen
Bianco, Orazio
Sacca, Carmen Daniela
Majello, Barbara
Donofrio, Vittoria
Bifano, Delfina
De Martino, Lucia
Quaglietta, Lucia
Cristofano, Adriana
Covelli, Eugenio Maria
Cinalli, Giuseppe
Ferrucci, Veronica
De Antonellis, Pasqualino
Zollo, Massimo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)

← 1 2 3 4 5 →